Diabetes update
In development [GID-NG10152] Expected publication date: TBC
In development [GID-NG10152] Expected publication date: TBC
In development [GID-NG10096] Expected publication date: 11 August 2021
In development [GID-NG10178] Expected publication date: 19 April 2023
In development [GID-NG10159] Expected publication date: TBC
In development [GID-NG10120] Expected publication date: 17 June 2021
In development [GID-NG10176] Expected publication date: 23 March 2023
In development [GID-NG10142] Expected publication date: 09 February 2022
In development [GID-NG10109] Expected publication date: 09 June 2021
In development [GID-NG10153] Expected publication date: 20 July 2022
In development [GID-NG10139] Expected publication date: 06 April 2022
In development [GID-NG10107] Expected publication date: 10 February 2021
In development [GID-NG10121] Expected publication date: 27 September 2021
In development [GID-NG10166] Expected publication date: TBC
In development [GID-NG10141] Expected publication date: 17 November 2021
In development [GID-NG10127] Expected publication date: 10 August 2022
In development [GID-NG10149] Expected publication date: 08 June 2022
In development [GID-NG10098] Expected publication date: TBC
In development [GID-NG10122] Expected publication date: 08 September 2021
In development [GID-NG10100] Expected publication date: 12 March 2021
In development [GID-NG10170] Expected publication date: 16 March 2022
In development [GID-NG10113] Expected publication date: 19 January 2022
In development [GID-NG10185] Expected publication date: TBC
In development [GID-NG10118] Expected publication date: 30 June 2021
In development [GID-NG10082] Expected publication date: 14 October 2021
In development [GID-NG10081] Expected publication date: 31 March 2021
In development [GID-NG10097] Expected publication date: 21 July 2021
In development [GID-NG10111] Expected publication date: 12 April 2021
In development [GID-NG10182] Expected publication date: 22 June 2022
In development [GID-NG10119] Expected publication date: 25 August 2021
In development [GID-NG10150] Expected publication date: 22 June 2022
In development [GID-NG10165] Expected publication date: 23 January 2023
In development [GID-CGWAVE0725] Expected publication date: 12 May 2022
In development [GID-NG10148] Expected publication date: 18 May 2022
In development [GID-NG10151] Expected publication date: 13 June 2022
In development [GID-NG10105] Expected publication date: 23 November 2021
In development [GID-NG10069] Expected publication date: TBC
In development [GID-NG10177] Expected publication date: 19 April 2023
In development [GID-NG10144] Expected publication date: 23 July 2021
In development [GID-NG10091] Expected publication date: 21 April 2021
In development [GID-NG10174] Expected publication date: 22 March 2023
In development [GID-NG10123] Expected publication date: 09 December 2021
In development [GID-NG10156] Expected publication date: TBC
In development [GID-NG10125] Expected publication date: 10 May 2022
In development [GID-NG10145] Expected publication date: 27 April 2022
In development [GID-NG10140] Expected publication date: 15 December 2021
In development [GID-NG10155] Expected publication date: 06 July 2022
This guideline covers the assessment, preparation, training and monitoring needed when using sedation in people aged under 19. It aims to help healthcare professionals decide when sedation is the most clinically and cost effective option for reducing pain and anxiety during operations for children and young people.
This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.
This guideline covers diagnosing, assessing, managing and monitoring anaemia in people with chronic kidney disease. It aims to improve care for people with chronic kidney disease by specifying how to assess when their anaemia needs treating, and by making detailed recommendations on treatment with erythropoietic stimulating agents (ESAs) and iron. It also covers detecting and managing ESA-resistant anaemia.
This guideline covers recognising, assessing, diagnosing and treating obsessive-compulsive disorder and body dysmorphic disorder in adults, young people and children (aged 8 years and older). It aims to improve the diagnosis and treatment of obsessive-compulsive disorder and body dysmorphic disorder. It includes recommendations on how families and carers may be able to support people with either of these conditions, and how they can get support for themselves.